Abbott Voluntarily Recalls Powder Formulas Manufactured at One Plant
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- Supermicro raises Q1 FY2027 revenue outlook on AI demand
- Dow outperforms as Wall Street rises, healthcare stocks lead gains
- Crude Inventory Fell 3.06 Million Barrels Last Week - EIA
Abbott (ABT) Falls After Some Infant Formulas Recalled Amid Cronobacter, Salmonella Complaints
February 18, 2022 10:44 AM ESTAbbott (NYSE: ABT) shares down 2.5% Friday after it issued a voluntary recall of powder formulas, including Similac, Alimentum, and... More



